{"id":33271,"date":"2023-06-28T14:01:34","date_gmt":"2023-06-28T13:01:34","guid":{"rendered":"https:\/\/faus-moliner.com\/el-pvl-tiene-la-consideracion-de-secreto-empresarial\/"},"modified":"2023-07-05T16:43:13","modified_gmt":"2023-07-05T15:43:13","slug":"el-pvl-tiene-la-consideracion-de-secreto-empresarial","status":"publish","type":"post","link":"https:\/\/faus-moliner.com\/ca\/el-pvl-tiene-la-consideracion-de-secreto-empresarial\/","title":{"rendered":"El PVL tiene la consideraci\u00f3n de secreto empresarial"},"content":{"rendered":"\n<p><strong>Antecedentes<\/strong><\/p>\n\n\n\n<p>En 2021, el Hospital Universitario de Gran Canaria Dr. Negr\u00edn inici\u00f3 el expediente de contrataci\u00f3n para el suministro de los principios activos dupilumab y sarilumab, mediante procedimiento negociado sin publicidad por razones de exclusividad. El lote referente a dupilumab qued\u00f3 desierto. Sin embargo, en la resoluci\u00f3n de adjudicaci\u00f3n de los lotes de sarilumab se incluy\u00f3 no s\u00f3lo la informaci\u00f3n relativa a sarilumab sino tambi\u00e9n el presupuesto base de licitaci\u00f3n desglosado por unidades del lote de dupilumab que hab\u00eda quedado desierto. El precio unitario que se mencionaba coincid\u00eda con el PVL de dupilumab.<\/p>\n\n\n\n<p>Contra dicha resoluci\u00f3n se present\u00f3 un recurso especial en materia de contrataci\u00f3n, argumentando que no se deb\u00eda publicar el precio unitario de dupilumab en una resoluci\u00f3n de adjudicaci\u00f3n de un contrato para el suministro de sarilumab, puesto que el lote relativo a dupilumab hab\u00eda quedado desierto. En el recurso, preparado por Joan Carles Bailach se argument\u00f3 que el PVL de dupilumab constitu\u00eda un secreto comercial, puesto que est\u00e1 elaborado a partir de informaci\u00f3n confidencial. El Tribunal Administrativo de Contratos P\u00fablicos de Canarias (TACP) inadmiti\u00f3 el recurso por falta de legitimaci\u00f3n activa. Esta decisi\u00f3n fue recurrida ante el TSJ de Canarias.<\/p>\n\n\n\n<p><strong>La posici\u00f3n del Tribunal Superior de Justicia de Canarias<\/strong><\/p>\n\n\n\n<p>El TSJ estima el recurso y, en relaci\u00f3n con el fondo del asunto, afirma que \u201clas compa\u00f1\u00edas farmac\u00e9uticas tienen un inter\u00e9s leg\u00edtimo en relaci\u00f3n con el precio de financiaci\u00f3n de los medicamentos, el cual es obtenido a partir de informaci\u00f3n reservada\u201d.<\/p>\n\n\n\n<p>Seg\u00fan el Tribunal, la divulgaci\u00f3n del PVL puede causar un da\u00f1o grave a la capacidad de competencia de la recurrente, \u201cdebiendo dicho precio ser considerado un secreto empresarial digno de protecci\u00f3n\u201d.<\/p>\n\n\n\n<p>El Tribunal afirma que el TACP entendi\u00f3 de forma err\u00f3nea que la recurrente carec\u00eda de legitimaci\u00f3n activa para recurrir, pese a no haber efectuado oferta al lote de dupilumab, ya que lo decisivo es que lo pretendido era \u201cproteger un secreto empresarial puesto en eventual riesgo por la actuaci\u00f3n administrativa al divulgar datos de un lote en el que no particip\u00f3 ninguna empresa\u201d.<\/p>\n\n\n\n<p>El Tribunal, por consiguiente, considera que la recurrente estaba suficientemente legitimada para recurrir contra la resoluci\u00f3n de adjudicaci\u00f3n.<\/p>\n\n\n\n<p>En relaci\u00f3n con la informaci\u00f3n que debe aparecer en las resoluciones de adjudicaci\u00f3n de contratos p\u00fablicos, el Tribunal es claro: la normativa que regula la publicidad de las licitaciones p\u00fablica no obliga a publicar el precio unitario de los medicamentos que se adquieren, siendo admisible publicar \u00fanicamente el precio total de la contrataci\u00f3n, sin desglose de las unidades adquiridas.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Antecedentes En 2021, el Hospital Universitario de Gran Canaria Dr. Negr\u00edn inici\u00f3 el expediente de contrataci\u00f3n para el suministro de los principios activos dupilumab y sarilumab, mediante procedimiento negociado sin publicidad por razones de exclusividad. El lote referente a dupilumab qued\u00f3 desierto. Sin embargo, en la resoluci\u00f3n de adjudicaci\u00f3n de los lotes de sarilumab se&#8230; <\/p>\n<div class=\"clear\"><\/div>\n<p><a href=\"https:\/\/faus-moliner.com\/ca\/el-pvl-tiene-la-consideracion-de-secreto-empresarial\/\" class=\"excerpt-read-more\">M\u00e9s informaci\u00f3<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[272,319],"tags":[],"coauthors":[521],"class_list":["post-33271","post","type-post","status-publish","format-standard","hentry","category-capsulas-ca","category-publicacions"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>El PVL tiene la consideraci\u00f3n de secreto empresarial - Faus Moliner<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/faus-moliner.com\/ca\/el-pvl-tiene-la-consideracion-de-secreto-empresarial\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"El PVL tiene la consideraci\u00f3n de secreto empresarial - Faus Moliner\" \/>\n<meta property=\"og:description\" content=\"Antecedentes En 2021, el Hospital Universitario de Gran Canaria Dr. Negr\u00edn inici\u00f3 el expediente de contrataci\u00f3n para el suministro de los principios activos dupilumab y sarilumab, mediante procedimiento negociado sin publicidad por razones de exclusividad. El lote referente a dupilumab qued\u00f3 desierto. Sin embargo, en la resoluci\u00f3n de adjudicaci\u00f3n de los lotes de sarilumab se... M\u00e9s informaci\u00f3\" \/>\n<meta property=\"og:url\" content=\"https:\/\/faus-moliner.com\/ca\/el-pvl-tiene-la-consideracion-de-secreto-empresarial\/\" \/>\n<meta property=\"og:site_name\" content=\"Faus Moliner\" \/>\n<meta property=\"article:published_time\" content=\"2023-06-28T13:01:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-05T15:43:13+00:00\" \/>\n<meta name=\"author\" content=\"Joan Carles Bailach\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"Faus Moliner\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minuts\" \/>\n\t<meta name=\"twitter:label3\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data3\" content=\"Joan Carles Bailach\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/faus-moliner.com\/ca\/el-pvl-tiene-la-consideracion-de-secreto-empresarial\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/faus-moliner.com\/ca\/el-pvl-tiene-la-consideracion-de-secreto-empresarial\/\"},\"author\":{\"name\":\"Faus Moliner\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/b62ac2c67efed1b6f50872c1d6366f90\"},\"headline\":\"El PVL tiene la consideraci\u00f3n de secreto empresarial\",\"datePublished\":\"2023-06-28T13:01:34+00:00\",\"dateModified\":\"2023-07-05T15:43:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/faus-moliner.com\/ca\/el-pvl-tiene-la-consideracion-de-secreto-empresarial\/\"},\"wordCount\":468,\"publisher\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/#organization\"},\"articleSection\":[\"Capsulas\",\"Publicacions\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/faus-moliner.com\/ca\/el-pvl-tiene-la-consideracion-de-secreto-empresarial\/\",\"url\":\"https:\/\/faus-moliner.com\/ca\/el-pvl-tiene-la-consideracion-de-secreto-empresarial\/\",\"name\":\"El PVL tiene la consideraci\u00f3n de secreto empresarial - Faus Moliner\",\"isPartOf\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/#website\"},\"datePublished\":\"2023-06-28T13:01:34+00:00\",\"dateModified\":\"2023-07-05T15:43:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/faus-moliner.com\/ca\/el-pvl-tiene-la-consideracion-de-secreto-empresarial\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/faus-moliner.com\/ca\/el-pvl-tiene-la-consideracion-de-secreto-empresarial\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/faus-moliner.com\/ca\/el-pvl-tiene-la-consideracion-de-secreto-empresarial\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/faus-moliner.com\/ca\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"El PVL tiene la consideraci\u00f3n de secreto empresarial\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#website\",\"url\":\"https:\/\/faus-moliner.com\/en\/\",\"name\":\"faus-moliner.com\",\"description\":\"Otro sitio realizado con WordPress\",\"publisher\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/faus-moliner.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#organization\",\"name\":\"Faus Moliner\",\"url\":\"https:\/\/faus-moliner.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg\",\"contentUrl\":\"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg\",\"width\":400,\"height\":283,\"caption\":\"Faus Moliner\"},\"image\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/2372042\/admin\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/b62ac2c67efed1b6f50872c1d6366f90\",\"name\":\"Faus Moliner\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/image\/88610ef99b0aa1c93ca33c569a053dac\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/be7b0f78e7edd64676ce7ea245b31f149a0cffff4b139c25ac02aaa676c19d67?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/be7b0f78e7edd64676ce7ea245b31f149a0cffff4b139c25ac02aaa676c19d67?s=96&d=mm&r=g\",\"caption\":\"Faus Moliner\"},\"url\":\"https:\/\/faus-moliner.com\/ca\/author\/moon\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"El PVL tiene la consideraci\u00f3n de secreto empresarial - Faus Moliner","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/faus-moliner.com\/ca\/el-pvl-tiene-la-consideracion-de-secreto-empresarial\/","og_locale":"ca_ES","og_type":"article","og_title":"El PVL tiene la consideraci\u00f3n de secreto empresarial - Faus Moliner","og_description":"Antecedentes En 2021, el Hospital Universitario de Gran Canaria Dr. Negr\u00edn inici\u00f3 el expediente de contrataci\u00f3n para el suministro de los principios activos dupilumab y sarilumab, mediante procedimiento negociado sin publicidad por razones de exclusividad. El lote referente a dupilumab qued\u00f3 desierto. Sin embargo, en la resoluci\u00f3n de adjudicaci\u00f3n de los lotes de sarilumab se... M\u00e9s informaci\u00f3","og_url":"https:\/\/faus-moliner.com\/ca\/el-pvl-tiene-la-consideracion-de-secreto-empresarial\/","og_site_name":"Faus Moliner","article_published_time":"2023-06-28T13:01:34+00:00","article_modified_time":"2023-07-05T15:43:13+00:00","author":"Joan Carles Bailach","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"Faus Moliner","Temps estimat de lectura":"3 minuts","Written by":"Joan Carles Bailach"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/faus-moliner.com\/ca\/el-pvl-tiene-la-consideracion-de-secreto-empresarial\/#article","isPartOf":{"@id":"https:\/\/faus-moliner.com\/ca\/el-pvl-tiene-la-consideracion-de-secreto-empresarial\/"},"author":{"name":"Faus Moliner","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/b62ac2c67efed1b6f50872c1d6366f90"},"headline":"El PVL tiene la consideraci\u00f3n de secreto empresarial","datePublished":"2023-06-28T13:01:34+00:00","dateModified":"2023-07-05T15:43:13+00:00","mainEntityOfPage":{"@id":"https:\/\/faus-moliner.com\/ca\/el-pvl-tiene-la-consideracion-de-secreto-empresarial\/"},"wordCount":468,"publisher":{"@id":"https:\/\/faus-moliner.com\/en\/#organization"},"articleSection":["Capsulas","Publicacions"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/faus-moliner.com\/ca\/el-pvl-tiene-la-consideracion-de-secreto-empresarial\/","url":"https:\/\/faus-moliner.com\/ca\/el-pvl-tiene-la-consideracion-de-secreto-empresarial\/","name":"El PVL tiene la consideraci\u00f3n de secreto empresarial - Faus Moliner","isPartOf":{"@id":"https:\/\/faus-moliner.com\/en\/#website"},"datePublished":"2023-06-28T13:01:34+00:00","dateModified":"2023-07-05T15:43:13+00:00","breadcrumb":{"@id":"https:\/\/faus-moliner.com\/ca\/el-pvl-tiene-la-consideracion-de-secreto-empresarial\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/faus-moliner.com\/ca\/el-pvl-tiene-la-consideracion-de-secreto-empresarial\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/faus-moliner.com\/ca\/el-pvl-tiene-la-consideracion-de-secreto-empresarial\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/faus-moliner.com\/ca\/"},{"@type":"ListItem","position":2,"name":"El PVL tiene la consideraci\u00f3n de secreto empresarial"}]},{"@type":"WebSite","@id":"https:\/\/faus-moliner.com\/en\/#website","url":"https:\/\/faus-moliner.com\/en\/","name":"faus-moliner.com","description":"Otro sitio realizado con WordPress","publisher":{"@id":"https:\/\/faus-moliner.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/faus-moliner.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/faus-moliner.com\/en\/#organization","name":"Faus Moliner","url":"https:\/\/faus-moliner.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg","contentUrl":"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg","width":400,"height":283,"caption":"Faus Moliner"},"image":{"@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/2372042\/admin\/"]},{"@type":"Person","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/b62ac2c67efed1b6f50872c1d6366f90","name":"Faus Moliner","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/image\/88610ef99b0aa1c93ca33c569a053dac","url":"https:\/\/secure.gravatar.com\/avatar\/be7b0f78e7edd64676ce7ea245b31f149a0cffff4b139c25ac02aaa676c19d67?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/be7b0f78e7edd64676ce7ea245b31f149a0cffff4b139c25ac02aaa676c19d67?s=96&d=mm&r=g","caption":"Faus Moliner"},"url":"https:\/\/faus-moliner.com\/ca\/author\/moon\/"}]}},"_links":{"self":[{"href":"https:\/\/faus-moliner.com\/ca\/wp-json\/wp\/v2\/posts\/33271","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/faus-moliner.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/faus-moliner.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/faus-moliner.com\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/faus-moliner.com\/ca\/wp-json\/wp\/v2\/comments?post=33271"}],"version-history":[{"count":5,"href":"https:\/\/faus-moliner.com\/ca\/wp-json\/wp\/v2\/posts\/33271\/revisions"}],"predecessor-version":[{"id":33361,"href":"https:\/\/faus-moliner.com\/ca\/wp-json\/wp\/v2\/posts\/33271\/revisions\/33361"}],"wp:attachment":[{"href":"https:\/\/faus-moliner.com\/ca\/wp-json\/wp\/v2\/media?parent=33271"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/faus-moliner.com\/ca\/wp-json\/wp\/v2\/categories?post=33271"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/faus-moliner.com\/ca\/wp-json\/wp\/v2\/tags?post=33271"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/faus-moliner.com\/ca\/wp-json\/wp\/v2\/coauthors?post=33271"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}